4 Comments
Apr 4, 2022·edited Apr 4, 2022

As much as this might be unfair to Bedoya, strategically, would it not be possible for Biden to nominate someone else with the same views on anti-trust and commercial regulation as Bedoya, but without the outspoken tweets on ICE and Republicans that raised their ire?

The biggest lesson that is reinforced for me by reading this: If you're a politician or aspire to a career in public service: don't tweet. Never tweet. Have your PR person do it instead. The risk of unnecessarily pissing off an opponent with an off-hand comment is just too high.

@Benjamin et al., thoughts?

Expand full comment

I was certainly disappointed yesterday. I wish they had been more prepared before the hearing. As you have listed, there were many points that weren’t listed that need a deep

Dive. BUT, I felt like some of the comments in Commissioner Wilson’s dissent, were directly from PCMA. They were PCMA’s standard talking points and NO one testified on the behalf of PBMs, so they must have met with PCMA before this meeting?? Where Did they come up with those reasons??

I liked some of Commissioner Wilson’s comments because she still thinks there is need for a study, but PBMs have increased the financial pressure on pharmacies every single year and it gets harder and harder for pharmacies to survive. I am concerned that their delay won’t come soon enough for some pharmacies. But, I remain hopeful. The impact that independent, compassionate pharmacists have on their communities is immeasurable.

Expand full comment